Stock Taper Total Investment Income: $37.0 million, up from $29.5 million in Q1 2026.
Net Investment Income (NII): $18.2 million, compared to $10.6 million in Q1 2026.
Fair Value of Total Investment Portfolio: $1.2 billion, a 35% increase from $886.3 million in Q1 2026.
Net Assets: Increased to $502.6 million from $438.2 million in Q1 2026.
NAV per Share: $11.91, down 2% from $12.13 in Q1 2026, impacted by $8.1 million in transaction expenses related to the SWK acquisition.
Dividend: Base dividend of $0.33 per share declared for Q3 2026, with spillover income of approximately $0.68 per share.
Debt Portfolio Yield: 14.2%, consistent with Q1 2026 but down from 15.4% year-over-year.
Leadership Changes: Mike Rovner appointed Co-CEO, enhancing leadership with extensive experience in technology and private credit.
SWK Acquisition: Completed on April 6, 2026, contributing positively to diversification and net investment income.
Portfolio Diversification: Focus on healthcare, life sciences, and consumer sectors, with a reduction in average loan size by 28% since June 30, 2025.
Capital Allocation Strategy: Emphasis on disciplined underwriting, share repurchases, and maintaining a strong origination pipeline.
Share Repurchase Program: BC Partners committed to purchasing up to 10% of outstanding shares over two years, signaling confidence in the company’s long-term value.
Dividend Coverage: Management anticipates covering dividends on a full-year basis, though quarterly NII may fluctuate.
Investment Pipeline: Strong deal flow expected from both legacy Runway and SWK platforms, with a focus on high-quality investments.
Declining NAV: The 2% decrease in NAV per share reflects transaction costs and market pressures.
Realized Losses: Net realized losses of $45.3 million in Q2, primarily due to issues with Marley Spoon and Blueshift.
Market Sentiment: Concerns regarding credit quality and software sector performance impacting stock valuation, with shares trading at a significant discount to NAV.
Leverage Ratio: Increased to 1.36x, raising concerns about financial flexibility and future capital allocation.
Capital Allocation Balance: Management indicated a cautious approach to balancing share repurchases and debt repayments, especially given the current leverage ratio.
SWK Contribution: The $0.05 per share accretion from SWK is expected to be a normalized run rate moving forward.
Software Portfolio Performance: No significant risk rating changes noted in the software portfolio, despite market anxieties.
Valuation Process: Management emphasized their rigorous valuation framework, with a focus on risk-based assessments rather than a blanket third-party review for all credits. This summary encapsulates the key points from Runway Growth Finance's Q2 2026 earnings call, highlighting both achievements and challenges faced by the company.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT